Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Gains from Investment Securities (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Gains from Investment Securities data on record, last reported at $77743.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 92.71% year-over-year to $77743.0; the TTM value through Sep 2025 reached $77743.0, down 92.71%, while the annual FY2025 figure was $361000.0, 81.42% down from the prior year.
  • Gains from Investment Securities reached $77743.0 in Q3 2025 per QTTB's latest filing, down from $242813.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $10.0 million in Q1 2022 and bottomed at -$127000.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $2.4 million, with a median of $600000.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 121.17% in 2021, then skyrocketed 9884.15% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$127000.0 in 2021, then soared by 7868.29% to $9.9 million in 2022, then tumbled by 89.3% to $1.1 million in 2023, then tumbled by 92.9% to $75000.0 in 2024, then rose by 3.66% to $77743.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $77743.0 in Q3 2025, $242813.0 in Q2 2025, and $65648.0 in Q1 2025.